Research Topics
Genomes and Genes
Species | Peter StenvinkelSummaryAffiliation: Karolinska Institutet Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular diseaseP Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
J Intern Med 268:456-67. 2010..Thus, novel treatment strategies are needed in this high-risk patient group...
Hibernating bears (Ursidae): metabolic magicians of definite interest for the nephrologistPeter Stenvinkel
Division of Renal Medicine, Department of Clinical Science Intervention and Technology, Karolinska University Hospital, Stockholm, Sweden
Kidney Int 83:207-12. 2013....
The vulnerable man: impact of testosterone deficiency on the uraemic phenotypeJuan Jesus Carrero
Correspondence and offprint requests to Peter Stenvinkel E mail
Nephrol Dial Transplant 27:4030-41. 2012..This review makes a case for consideration of screening and better management of hypogonadism in men undergoing dialysis...
Hypogonadism in males with chronic kidney disease: another cause of resistance to erythropoiesis-stimulating agents?Peter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Contrib Nephrol 178:35-9. 2012..Thus, a randomized controlled trial is needed to test the possibility that restoration of testosterone levels in hypogonadal CKD males may translate into lower prevalence of anemia, better ESA responsiveness and better quality of life...
Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased?Peter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital at Huddinge, Karolinska Institutet, SE 141 86 Stockholm, Sweden
Nat Rev Nephrol 8:72-4. 2012..Several publications in 2011 addressed how interventions can modify cardiovascular risk factors and improve outcomes...
[Cardiovascular disease increases the risk of renal failure]Peter Stenvinkel
Karolinska Universitetssjukhuset Huddinge, Stockholm
Lakartidningen 104:2495. 2007
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?Peter Stenvinkel
Department of Renal Medicine, K56, Karolinska University Hospital at Huddinge, 141 86 Stockholm, Sweden
Clin J Am Soc Nephrol 3:505-21. 2008..Finally, two novel disciplines, proteomics and epigenetics, will be discussed, because these tools may be helpful in the understanding of the discussed vascular risk factors...
Epigenetics and the uremic phenotype: a matter of balancePeter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Contrib Nephrol 161:55-62. 2008....
Resolved: being fat is good for dialysis patients: the Godzilla effect: conPeter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
J Am Soc Nephrol 19:1062-4. 2008
Inflammation in end-stage renal disease: the hidden enemyPeter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden
Nephrology (Carlton) 11:36-41. 2006..Elevated CRP in dialysis patients could be evaluated at three different levels: (i) national/regional level; (ii) dialysis unit level; and (iii) individual patient level...
Does the uremic milieu affect the epigenotype?Peter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden
J Ren Nutr 19:82-5. 2009....
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patientsPeter Stenvinkel
Division of Renal Medicine K56, Karolinska University Hospital at Huddinge, 14186 Stockholm, Sweden
Clin J Am Soc Nephrol 1:281-7. 2006..2 deltaOD630/min per mg protein) MPO activity compared with 18 who had diabetes and were not taking statins. This cross-sectional study suggests that both diabetes and statin treatment affect MPO activity in prevalent HD patients...
Adiponectin in chronic kidney disease: a complex and context sensitive clinical situationPeter Stenvinkel
Divisions of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
J Ren Nutr 21:82-6. 2011..Until nutritional and pharmacological treatment strategies that increase adiponectin in uremic patients can be advocated nephrologists have an important task to unravel the observed paradoxes...
New insights on inflammation in chronic kidney disease-genetic and non-genetic factorsPeter Stenvinkel
Division of Renal Medicine K56, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital at Huddinge, 14186 Stockholm, Suède
Nephrol Ther 2:111-9. 2006..Indeed, multiple cytokine DNA polymorphisms may affect the inflammatory state, the clinical phenotype as well as outcome in this patient population...
C-reactive protein--does it promote vascular disease?Peter Stenvinkel
Department of Renal Medicine K56, Karolinska Institutet, Karolinska University Hospital at Huddinge
Nephrol Dial Transplant 21:2718-20. 2006
Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?P Stenvinkel
Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
J Intern Med 261:488-99. 2007..DNA methylation is an important cellular mechanism modulating gene expression associated with ageing, inflammation and atherosclerotic processes...
Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney diseaseKeisuke Matsubara
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
J Nephrol 22:774-82. 2009..The production and expression of osteoprotegerin (OPG), a bone regulating protein, is regulated by inflammatory cytokines...
Serum albumin as predictor of nutritional status in patients with ESRDThiane Gama-Axelsson
Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Clin J Am Soc Nephrol 7:1446-53. 2012..This study investigated serum albumin and its correlation with several markers of nutritional status in incident and prevalent dialysis patients...
Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney diseaseJuan Jesus Carrero
Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden
Nephrol Dial Transplant 27:709-15. 2012..Additionally, we studied associations between endogenous testosterone levels and ESA dose (U/kg/week) in 126 ESA-treated men undergoing haemodialysis (HD)...
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney diseaseMohamed E Suliman
Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Divisions of Renal Medicine and Baxter Novum, Karolinska University Hospital Huddinge, Stockholm, Sweden
Clin J Am Soc Nephrol 3:976-85. 2008..Albuminuria and inflammation predict cardiovascular events. Pentraxin 3, an inflammatory mediator produced by, among others, endothelial cells, may have a role in atherogenesis...
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patientsJuan Jesus Carrero
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Clin Nutr 27:557-64. 2008..We tested the usefulness of a simple observer subjective muscle atrophy (MA) grading in relation to morbidity and mortality in ESRD patients...
Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortalityKeisuke Matsubara
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Blood Purif 26:284-90. 2008..We have investigated the relationship between bone mineral density (BMD) and inflammation, wasting, CVD and mortality in ESRD patients...
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRDHirokazu Honda
Division of Renal Medicine, Department of Clinical Science, Interventions and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Am J Kidney Dis 47:139-48. 2006..This comparative analysis indicates that of these biomarkers, IL-6 level may be the most reliable predictor of CVD and mortality in patients with ESRD...
Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levelsJuan J Carrero
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Nephrol Dial Transplant 25:901-6. 2010..We hypothesized that increased visfatin levels in CKD patients may be involved in the regulation of appetite and nutrient homeostasis...
Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?Jonas Axelsson
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Am J Nephrol 28:669-76. 2008..We studied circulating AHSG (ELISA) and two common functional AHSG gene polymorphisms (at amino acids Thr248Met (C-T) and Thr256Ser (C-G) using Pyrosequencing) and related these to multiple components of the metabolic syndrome...
Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapyMohamed E Suliman
Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Am J Kidney Dis 44:455-65. 2004..Thus, inflammation may contribute to the reverse association between tHcy level and mortality in patients with CKD starting renal replacement therapy...
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortalityHirokazu Honda
Division of Renal Medicine and Baxter Novum, Department of Clinical Science Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Am J Clin Nutr 86:633-8. 2007..Overweight in ESRD patients, however, is reported to be associated with better survival...
Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRDJonas Axelsson
Division of Renal Medicine, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Am J Kidney Dis 46:628-34. 2005..Although truncal fat is associated with secretion of proinflammatory cytokines, this secretion appears not to have inhibitory effects on epoetin sensitivity in the presence of high leptin levels...
Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patientsJuan J Carrero
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Clin J Am Soc Nephrol 4:110-8. 2009..Reduced soluble TNF-like weak inducer of apoptosis (sTWEAK) plasma levels have been reported both in patients with subclinical atherosclerosis and CKD...
Associations between circulating inflammatory markers and residual renal function in CRF patientsRoberto Pecoits-Filho
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Am J Kidney Dis 41:1212-8. 2003....
Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survivalSunna Snaedal
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Am J Kidney Dis 53:1024-33. 2009..Patients with chronic kidney disease stage 5 have high comorbidity and are prone to inflammation that may contribute to the high cardiovascular mortality risk...
Adipose tissue and its relation to inflammation: the role of adipokinesJonas Axelsson
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
J Ren Nutr 15:131-6. 2005..Such an imbalance may, via effects on the central nervous system and the vasculature, contribute to wasting, atherosclerosis, and insulin resistance--all common features of ESRD...
Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal diseaseYukio Maruyama
Department of Clinical Science, Divisions of Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden
Blood Purif 23:384-93. 2005..Interleukin-1beta (IL-1beta) and its receptor antagonist (IL-1Ra) may play a pivotal role in the pathogenesis of wasting and inflammation...
Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patientsAlessandro Valli
Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Clin Chim Acta 395:106-10. 2008..Although, S-adenosylhomocysteine (SAH) levels have been linked to CVD in non-renal populations, such relationship has not been evaluated in CKD...
Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortalityMengli Tong
Division of Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Clin J Am Soc Nephrol 2:889-97. 2007..Plasma protein pentraxin 3 concentrations are elevated in a wide range of diseased states. However, no study has evaluated protein pentraxin 3 in patients with chronic kidney disease...
J-shaped mortality relationship for uric acid in CKDMohamed E Suliman
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Am J Kidney Dis 48:761-71. 2006..Moreover, uric acid level was associated with calcium/phosphate metabolism, dyslipidemia, and inflammation...
Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patientsJuan J Carrero
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Kidney Int 79:749-56. 2011..Thus, since these patients were more anorectic, our results provide a clinical scenario where ghrelin therapies may be particularly useful...
Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patientsMichal Chmielewski
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden
Blood Purif 26:555-60. 2008..The present study was undertaken to clarify the impact of the two polymorphisms on lipid parameters and cardiovascular risk in incident dialysis patients...
Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetiteJuan Jesus Carrero
Division of Renal, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Karolinska University Hospital at Huddinge, Stockholm, Sweden
Am J Clin Nutr 85:695-701. 2007..Anorexia is common in chronic kidney disease and worsens as the disease progresses. Sex hormones and inflammatory cytokines may be related to feeding behavior...
Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortalityMakoto Watanabe
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Am J Clin Nutr 87:1860-6. 2008..Histidine is considered as an antiinflammatory and antioxidant factor. Histidine deficiency may contribute to an impaired nutritional state in patients with chronic kidney disease (CKD)...
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapyMohamed E Suliman
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Am J Kidney Dis 40:480-8. 2002..Malnutrition, hypoalbuminemia, and DM in patients with CRF influence sAA levels, mainly plasma tHcy, which should be considered when evaluating hyperhomocysteinemia as a cardiovascular risk factor...
Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation?Siamak Haghdoost
Department of Genetics, Microbiology and Toxicology, Stockholm University, Stockholm, Sweden
Antioxid Redox Signal 8:2169-73. 2006..Serum levels of 8-oxo-dG, in combination with other inflammatory markers, serve as useful diagnostic tools for identification of patients in risk for inflammatory complications...
Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKDJonas Axelsson
Division of Renal Medicine, Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Am J Kidney Dis 48:916-25. 2006..Here, we investigate this putative relationship in patients with chronic kidney disease (CKD) by using the novel macrophage marker soluble (s)CD163...
Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKDJonas Axelsson
Division of Renal Medicine, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden
Am J Kidney Dis 49:237-44. 2007....
Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney diseaseMohammed E Suliman
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Am J Clin Nutr 82:342-9. 2005....
Clinical importance of an elevated circulating chemerin level in incident dialysis patientsTae Yamamoto
Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden
Nephrol Dial Transplant 25:4017-23. 2010..We explored possible links between chemerin and various clinical, nutritional and biochemical markers as well as its association with 5-year all-cause mortality...
Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patientsErnesto Rodríguez-Ayala
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, K56, Karolinska University Hospital at Huddinge, 141 86 Stockholm, Sweden
Atherosclerosis 180:333-40. 2005..Inflammation and oxidative stress biomarkers are interrelated in ESRD. Inflammatory cell signal pathways, such as NFkappaB, are activated by CML-modification of proteins via RAGE...
Truncal fat mass as a contributor to inflammation in end-stage renal diseaseJonas Axelsson
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital, Stockholm
Am J Clin Nutr 80:1222-9. 2004....
Gene polymorphism association studies in dialysis: the nutrition-inflammation axisPeter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Karolinska University Hospital at Huddinge, Stockholm, Sweden
Semin Dial 18:322-30. 2005....
Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphismXin Wang
Divisions of Renal Medicine and Baxter Novum, Karolinska Institutet, K 56 Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden
Nephrol Dial Transplant 22:196-202. 2007..In this longitudinal cohort study, we investigated the impact of the UCP2 insertion/deletion (ins/del) polymorphism on body composition changes in ESRD patients starting dialysis...
Prevalence and clinical implications of testosterone deficiency in men with end-stage renal diseaseJuan Jesus Carrero
Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden
Nephrol Dial Transplant 26:184-90. 2011..However, the prevalence of testosterone deficiency in end-stage renal disease (ESRD) is not well defined. We hereby explore the prevalence and correlates of clinical testosterone deficiency in a large cohort of ESRD male patients...
Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysisAntonio Carlos Cordeiro
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Nephrol Dial Transplant 25:562-8. 2010..We tested the hypothesis that abdominal fat deposition in HD patients is a risk factor associated with both increased inflammation and protein-energy wasting (PEW), as well as elevated mortality risk...
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapyMohammed E Suliman
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
J Am Soc Nephrol 14:1614-22. 2003..However, in this small cohort, the plasma pentosidine content did not predict outcome. Thus, accumulation of plasma pentosidine is unlikely to be an appropriate clinically useful marker to predict mortality in ESRD patients...
Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKDJuan Jesus Carrero
Divison of Renal Medicine, Karolinska Institutet, Sweden
Clin J Am Soc Nephrol 7:207-15. 2012..Given the elevated cardiovascular risk of CKD, this study examined links between prolactinemia, vascular derangements, and outcomes...
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuinPeter Stenvinkel
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska University Hospital, Stockholm, Sweden
Kidney Int 67:2383-92. 2005..In the present study, we evaluated the association between fetuin-A, clinical phenotype, and outcome, as well as the impact of fetuin gene (AHSG) polymorphisms on the protein product and outcome...
Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patientsQunying Guo
1Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Nephrol Dial Transplant 24:3468-73. 2009..Soluble VEGF receptors (sVEGFR)-1 and -2 are circulating endogenous modulators of VEGF activity. We thus studied the relationship between sVEGFR-1 and -2 and survival in a cohort of prevalent haemodialysis (HD) patients...
N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patientsQunying Guo
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden
Am J Nephrol 29:516-23. 2009..We hypothesized that common confounders, such as protein-energy wasting (PEW) and inflammation could modulate this relationship...
Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney diseaseTetsu Miyamoto
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Nephrol Dial Transplant 26:2231-7. 2011..While chronic kidney disease (CKD) is associated with dysmetabolism including a marked insulin resistance, the postprandial response has not comprehensively been studied in CKD patients...
Serum retinol-binding protein concentration and its association with components of the uremic metabolic syndrome in nondiabetic patients with chronic kidney disease stage 5Jonas Axelsson
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Am J Nephrol 29:447-53. 2009..Although RBP is elevated in type 2 diabetics with mild CKD, its role in advanced CKD is not well studied. We hypothesized that altered RBP levels in CKD could be one factor contributing to the uremic insulin resistance...
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?Hannes Olauson
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Nephrol Dial Transplant 25:3033-8. 2010..Herein, our aim was to evaluate the relation between FGF23 and mortality, including the impact of gender and cardiovascular disease (CVD), in a Swedish cohort of 'incident' dialysis patients...
Use of single-nucleotide polymorphisms in the search for genetic modifiers of the uremic phenotypeAnna Witasp
Department of Molecular Medicine and Surgery, Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden
J Ren Nutr 17:17-22. 2007....
Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factorsAlessandro Valli
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden
Clin Chim Acta 379:87-94. 2007..Advanced oxidation protein products (AOPP), a suggested protein biomarker of oxidative stress, are elevated in patients with chronic kidney disease (CKD), who also often suffer from hypertriglyceridemia...
Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal studyErnesto Rodriguez Ayala
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, Stockholm, Sweden
Nephrol Dial Transplant 19:421-6. 2004..Changes in plasma ghrelin during 12 months of peritoneal dialysis treatment are associated with changes in body composition...
Influence of erythropoiesis-stimulating agents on glycated hemoglobin in nondiabetic kidney diseases at the start of dialysisAntonio Carlos Cordeiro
Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden
Am J Nephrol 33:17-24. 2011..We evaluated the association of HbA₁(C) with other parameters of glucose homeostasis and tested its association with ESA use and mortality in nondiabetic incident dialysis patients...
Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney diseaseMohamed E Suliman
Department of Clinical Science, Intervention and Technology, Divisions of Renal Medicine and Baxter Novum, Karolinska Institutet, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden
Adv Clin Chem 46:217-62. 2008..Recent experimental and clinical studies also suggest an intriguing link between fetuin-A, insulin resistance, and the metabolic syndrome...
Identifying and managing malnutrition stemming from different causesSung Hee Chung
Division of Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Perit Dial Int 27:S239-44. 2007..The present review briefly discusses the causes of PEM/W, the methods most commonly used to identify the condition, and the new management strategies available...
Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patientsSawako Kato
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital Huddinge, K 56, 141 86, Stockholm, Sweden
Nephrol Dial Transplant 22:2571-7. 2007....
Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survivalTetsu Miyamoto
Division of Baxter Novum, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden
Clin J Am Soc Nephrol 6:1001-8. 2011..Follistatin mediates muscle growth and bone mineralization. At present, it is unknown whether circulating follistatin levels are altered in chronic kidney disease (CKD) or links to CKD risk factors and outcomes...
Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal diseaseAlicia Marchlewska
Department of Molecular Medicine, Divisions of Renal Medicine and Baxter Novum, Karolinska Institutet, Stockholm, Sweden
Kidney Int 66:46-50. 2004..Although plasma levels of adiponectin, a recently discovered anti-inflammatory and antiatherogenic adipocytokine, are markedly elevated in ESRD, gene expression of adiponectin (ApM1) has not been analyzed in ESRD patients...
Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patientsAyumu Nakashima
Division of Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Clin J Am Soc Nephrol 5:2213-9. 2010..Whether alterations at this level contribute to the increased mortality observed in patients on dialysis is currently unknown...
Risk factors for cardiovascular disease in patients undergoing peritoneal dialysisElvia Garcia Lopez
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Perit Dial Int 27:S205-9. 2007....
The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective studyMarcelo M Nascimento
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, Karolinka University Hospital Huddinge, Stockholm, Sweden
Nephrol Dial Transplant 19:2803-9. 2004..Thus, persistent, rather than occasional, inflammation is an important predictor of death in HD patients...
Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposalJuan Jesus Carrero
Department of Clinical Science, Karolinska Institutet, Stockholm, Sweden
Clin J Am Soc Nephrol 4:S49-55. 2009....
Cytokine dysregulation in chronic kidney disease: how can we treat it?Juan Jesus Carrero
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Blood Purif 26:291-9. 2008....
Soluble adhesion molecules in end-stage renal disease: a predictor of outcomeMohamed E Suliman
Department of Renal Medicine and Baxter Novum, K56, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden
Nephrol Dial Transplant 21:1603-10. 2006..CONCLUSIONS: In ESRD patients, sICAM-1 and sVCAM-1 are independent predictors of all cause and cardiovascular death. The use of ACEI/ARB or CCB was associated with decreased concentrations of soluble adhesion molecules...
The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutionsQiang Yao
Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Karolinska Institutet, Stockholm, Sweden
Nephron Exp Nephrol 109:e71-8. 2008....
Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectinPeter Stenvinkel
Division of Renal Medicine and Baxter Novum, Department of Clinical Science and Neurogenetics Unit, Karolinska Institutet, Stockholm, Sweden
Kidney Int 65:274-81. 2004..Adiponectin is an adipocytokine that may have significant anti-inflammatory and anti-atherosclerotic effects. Low adiponectin levels have previously been found in patients with high risk for CVD...
Systemic and local inflammation in peritoneal dialysis: mechanisms, biomarkers and effects on outcomeAntonio Carlos Cordeiro
Department of Clinical Science, Intervention and Technology Karolinska Institutet, Stockholm, Sweden
Contrib Nephrol 163:132-9. 2009..Understanding the pathophysiology of inflammation in PD is essential for the adoption of adequate strategies to improve both membrane and patient survival...
Inflammation and oxidative stress in ESRD--the role of myeloperoxidaseYukio Maruyama
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska University Hospital at Huddinge, Karolinska Institutet, Stockholm, Sweden
J Nephrol 17:S72-6. 2004..Nutritional and pharmacological antioxidant strategies that interfere with chlorinated MPO-associated oxidative stress pathways need to be investigated in the ESRD patient population...
C-reactive protein in end-stage renal disease: are there reasons to measure it?Peter Stenvinkel
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
Blood Purif 23:72-8. 2005....
Chronic systemic inflammation in dialysis patients: an update on causes and consequencesQiang Yao
Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Karolinska Institutet, Stockholm, Sweden
ASAIO J 50:lii-lvii. 2004....
A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patientsPeter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Nephrol Dial Transplant 17:1266-74. 2002..Consequently, we need other nutritional markers that can predict outcome. However, males and females differ as regards body composition and it is not known how this may influence the predictive power of different nutritional markers...
Inflammation in end-stage renal disease: sources, consequences, and therapyPeter Stenvinkel
Department of Renal Medicine K56, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Semin Dial 15:329-37. 2002....
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectinMahmut Ilker Yilmaz
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, K56 Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden
Nephrol Dial Transplant 23:1621-7. 2008..We hypothesized that altered kidney clearance and/or metabolism of vasoactive peptides occurring during proteinuria could link early diabetic nephropathy to cardio vascular disease (CVD)...
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problemPeter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, K56 Huddinge University Hospital, 141-86 Huddinge, Sweden
J Am Soc Nephrol 14:1927-39. 2003
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?Peter Stenvinkel
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Kidney Int 62:1791-8. 2002..However, although sex hormones may influence serum levels of inflammatory proteins, gender has not been taken into consideration in previous studies of inflammation and outcome in ESRD patients...
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatmentRoberto Pecoits-Filho
Division of Renal Medicine, Department of Clinical Science, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Nephrol Dial Transplant 17:1684-8. 2002..The predictive power of sIL-6R levels on outcome is also unknown in this patient population...
Statins to treat chronic inflammation in dialysis patients--is this feasible?Olof Heimburger
Department of Renal Medicine, Karolinska University Hospital, Karolinska Institutet Stockholm, Sweden
Perit Dial Int 27:254-7. 2007
Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal diseaseHadi Molanaei
Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
Eur J Clin Pharmacol 66:269-73. 2010..We studied the influence of three factors on drug disposition: genetic polymorphism, impaired renal excretion of drug metabolites, and the possible elimination by hemodialysis (HD), using codeine as a model drug...
Low serum testosterone increases mortality risk among male dialysis patientsJuan Jesus Carrero
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
J Am Soc Nephrol 20:613-20. 2009..Hypogonadism may be an additional treatable risk factor for patients with chronic kidney disease...
Leptin, ghrelin, and proinflammatory cytokines: compounds with nutritional impact in chronic kidney disease?Peter Stenvinkel
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Huddinge University Hospital, Sweden
Adv Ren Replace Ther 10:332-45. 2003....
Appetite disorders in uremiaJuan Jesus Carrero
Division of Renal Medicine, CLINTEC, Karolinska Institutet, Stockholm, Sweden
J Ren Nutr 18:107-13. 2008..Based on megestrol acetate interventions and the recent observation that sex may modulate uremic appetite behavior, the potential role of sex hormones in treating chronic kidney disease anorexia needs to be further explored...
Being an inflamed peritoneal dialysis patient - a Dante's journeyJuan Jesus Carrero
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Contrib Nephrol 150:144-51. 2006..Finally, we briefly explore potential strategies specifically aiming at reducing intraperitoneal and systemic inflammation in PD patients...
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failureP Stenvinkel
Department of Clinical Science, Karolinska Institutet, Huddinge University Hospital, Sweden
Kidney Int 55:1899-911. 1999..In chronic renal failure (CRF), the prevalence of an acute-phase response has been associated with an increased mortality...
Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patientsA Witasp
Department of Molecular Medicine and Surgery, Karolinska Institutet, Centre for Molecular Medicine, L8 00 Karolinska University Hospital, 17176 Stockholm, Sweden
J Intern Med 269:410-9. 2011....
Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapyQ Yao
Division of Baxter Novum and Renal Medicine, Department of Clinical Science, Karolinska Institute, Stockholm, Sweden
Atherosclerosis 182:105-11. 2005..The aim of this study was to clarify whether the PPAR-gamma 161C/T and PPAR-gamma2 Pro12Ala single-nucleotide polymorphisms (SNPs) influence the inter-individual variance of inflammation and mortality in ESRD patients...
Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistanceJ Axelsson
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital at Huddinge, Stockholm, Sweden
Kidney Int 69:596-604. 2006..Renal function is an important factor to take into account in clinical studies relating insulin sensitivity to inflammatory biomarkers in CKD as well as in patients with diabetes mellitus, who often have an impaired renal function...
Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?J Axelsson
1ivisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital at Huddinge, Stockholm, Sweden
Eur J Clin Nutr 60:718-26. 2006..In the present study, we investigate the influence of decreasing residual renal function as well as of chronic inflammation on the IGF system to assess its usefulness in this patient group...
The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortalityM E Suliman
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
QJM 101:397-405. 2008..However, no data are available on PTX-3 and its relationship with clinical outcome in prevalent dialysis patients...
Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequencesM I Yilmaz
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital at Huddinge, Stockholm, Sweden
Clin Nephrol 68:1-9. 2007..A more thorough characterization of uremic retention solutes with regard to their specific pro- and anti-inflammatory properties is needed...
Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patientsG Metry
Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital Huddinge, Stockholm, Sweden
Eur J Clin Invest 38:804-11. 2008..Chronic inflammation, which is common in CKD, may promote vascular calcification...
